Drug Information Association Logo
« Back to Listing

Broadening Health Care Communications: Learnings from Health Authority Initiatives

Medical Communication, Medical Writing, and Medical Science Liaison

Day & Time:
June 18, 1:30PM - 3:00PM (Pacific Standard Time)

Session Number:

Room Number:



Broadening Health Care Communications: Learnings from Health Authority Initiatives

Stacey M. Fung, PharmD
Associate Director, Medical Communications
Genentech, A Member of the Roche Group, United States

This session will include presentations reviewing FDA collaborations to broaden the reach of health messages to the public and the pharmaceutical industry, learnings from the EMA and how patients shape product information, and available information on expanded access trials with ways to best communicate on these topics.

Learning Objective(s):
Describe innovative collaboration models with FDA for communicating information; Discuss how patients participate on the review of product information and communications produced by the EMA; Identify available information expanded access programs including ways forthe pharmaceutical industry to share this information with patients and health care providers.

Presentation(s) & Speaker(s):
The FDA and Innovative Collaborations to Broaden the Reach of Health Care Messages to the Public
Anna M Fine, PharmD, MS
Director, Health Professional Liaison Program, Office of the Commissioner
FDA, United States

Industry Perspective
Julia Petses, PharmD
Director, Medical Information Services Oncology/Hematology
Sanofi US, United States

EMA Perspective on Communicating Health Care Messages to the Public
Martin Harvey Allchurch, LLM
Principal Administrator, International Affairs
European Medicines Agency, European Union, United Kingdom